Sponsor Pipeline

Shanghai SciBrunch Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07359066 An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to… Advanced Solid Tumors Recruiting
Get alerts when Shanghai SciBrunch Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free